Estonia vs Republic of Korea: Share of adolescent girls vaccinated against human papillomavirus
Estonia
63.0%
in 2024
Republic of Korea
65.0%
in 2024
Estonia rank
41st
Republic of Korea rank
38th
Share of adolescent girls vaccinated against human papillomavirus over time
- Estonia
- Republic of Korea
How they compare
Republic of Korea currently reports 65.0% against 63.0% in Estonia, a difference of 2.0%.
Across all 6 years both countries report, Republic of Korea has been ahead every year.
Estonia ranks 41st and Republic of Korea ranks 38th of 74 countries.
Republic of Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Estonia | Republic of Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 48.0% | 64.0% | 16.0% | Republic of Korea |
| 2020s | 56.6% | 69.4% | 12.8% | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of adolescent girls vaccinated against human papillomavirus, Estonia or Republic of Korea?
- Republic of Korea, at 65.0% against 63.0% in Estonia as of 2024.
- What is the difference in share of adolescent girls vaccinated against human papillomavirus between Estonia and Republic of Korea?
- 2.0%, with Republic of Korea ahead.
- How many years of comparable data are there for Estonia and Republic of Korea?
- 6 years are reported by both, from 2019 to 2024.
- How do Estonia and Republic of Korea rank globally for share of adolescent girls vaccinated against human papillomavirus?
- Estonia ranks 41st and Republic of Korea ranks 38th of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as Share of adolescent girls vaccinated against human papillomavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.